Hormonal Influences on Sleep Apnea

Two key female hormones — estrogen and progesterone — have significant effects on breathing and airway function during sleep. Understanding their role helps explain why women's sleep apnea risk changes across the lifespan.

Progesterone is a respiratory stimulant. It increases breathing drive and helps maintain the activity of airway dilator muscles — the muscles that keep the airway open. During the luteal phase of the menstrual cycle and during pregnancy, elevated progesterone actually provides some protection against airway collapse.

Estrogen influences fat distribution, airway tissue composition, and possibly airway muscle function. It also has indirect effects through its influence on progesterone receptors and overall hormonal balance. When estrogen declines, fat redistribution (including to the neck area) can further narrow the airway.

During perimenopause and menopause, estrogen and progesterone levels drop significantly. This decline removes key protective factors for airway patency:

First, the loss of progesterone's stimulatory effect on airway dilator muscles means the airway is more prone to collapse during sleep. Second, the loss of estrogen contributes to changes in fat distribution — including increased fat deposition around the neck — which physically narrows the airway. Third, age-related decreases in muscle tone and tissue elasticity compound these effects.

The result is a significantly increased risk of airway collapse during sleep, explaining why postmenopausal women are two to three times more likely to have obstructive sleep apnea than premenopausal women.

Pregnancy involves dramatic hormonal shifts that affect breathing during sleep. Progesterone levels rise significantly during pregnancy — which stimulates breathing but can also contribute to airway muscle relaxation. Estrogen also rises, contributing to nasal mucosal swelling and congestion.

Combined with the physical changes of pregnancy (weight gain, reduced lung volume from the growing uterus, and elevated diaphragm), these hormonal effects contribute to increased sleep-disordered breathing risk — particularly in the third trimester.

Hormone replacement therapy (HRT) is sometimes prescribed for menopausal symptoms like hot flashes, night sweats, and mood changes. While HRT may help alleviate these symptoms, it is not a treatment for obstructive sleep apnea.

Research on HRT and sleep-disordered breathing has produced mixed results. Some studies suggest modest improvements in sleep-disordered breathing with HRT, but the effects are not strong enough to treat clinically significant sleep apnea. Women with sleep apnea need evidence-based therapies — oral appliance therapy, CPAP, or lifestyle modifications — regardless of whether they use HRT.

Polycystic ovary syndrome (PCOS) is a hormonal condition characterized by elevated androgens, insulin resistance, and often elevated body weight. Women with PCOS have a significantly higher rate of obstructive sleep apnea — research suggests up to 70% of women with PCOS may have sleep-disordered breathing.

The connection between PCOS and sleep apnea is thought to involve insulin resistance, inflammation, and altered hormone levels. Women with PCOS who experience fatigue, snoring, or poor sleep should discuss sleep evaluation with their provider.

Women who are perimenopausal, menopausal, pregnant, or have hormonal conditions like PCOS should be aware of the increased risk of sleep-disordered breathing. If you experience snoring, breathing pauses, insomnia, morning headaches, or excessive daytime fatigue, a sleep evaluation can determine whether sleep apnea is present.

A home sleep test is a convenient, comfortable way to begin the diagnostic process. Treatment with oral appliance therapy or CPAP can significantly improve sleep quality, energy, and long-term health outcomes.